Interstitial pulmonary disease caused by amiodarone: a case report

Authors

  • Maribel Sandrino Sánchez Especialista de Primer Grado en Medicina Interna. Instructora. Hospital Provincial Docente Clínico Quirúrgico Dr. "León Cuervo Rubio". Pinar del Río.
  • Luis Mitjans Fernández Especialista de Primer Grado en Medicina Interna. Asistente. Hospital Provincial Docente Clínico Quirúrgico Dr. "León Cuervo Rubio". Pinar del Río.
  • Yuniesky Madraso Calzadilla Especialista de Primer Grado en Medicina Interna. Instructor. Hospital Provincial Docente Clínico Quirúrgico Dr. "León Cuervo Rubio". Pinar del Río.
  • Miguel Azcuy Ruiz Especialista de Primer Grado en Medicina Interna. Hospital Provincial Docente Clínico Quirúrgico Dr. "León Cuervo Rubio". Pinar del Río.
  • Idalmis Trujillo Milo Especialista en Medicina General Integral y de Primer Grado en Medicina Interna. Máster en Emergencias Médicas. Hospital Provincial Docente Clínico Quirúrgico Dr. "León Cuervo Rubio". Pinar del Río.

Keywords:

Amiodarone, Dyspnea, Interstitial lung diseases.

Abstract

A 62 year-old, Caucasian, female patient having health personal records of paroxysmal supraventricular tachycardia maintaining a daily treatment with amiodarone (400mg) during 4 years presented a respiratory disorder characterized by dyspnea at middle and great efforts, not intense cough with whitish and scarce expectoration. The patient attended to the emergency room at “Leon Cuervo Rubio” General Hospital in Pinar del Rio. Physical examination showed the presence of crepitus-indux in the inferior third of left pulmonary field and the base of the right lung; X-ray of thorax proved a diffuse opacity having cottony aspect in the inferior half of both pulmonary fields presenting inflammatory features. The patient was admitted to complete a clinical study and pharmacological treatment. Considering the clinical evolution of the patient and radiological findings, antibiotic therapy was indicated without radiological improvement due to the extension of lesions, then deepening in the clinical study. Amiodarone was discontinued, and the treatment with steroids started, showing improvement of the symptoms, where the disappearance of crepitus-indux was clear; from radiological point of view a remarkable progress was observed. The patient was discharged from the hospital with steroid treatment and the follow-up was recommended, and at month there were no symptoms with a marked radiological improvement; a progressive diminution of steroid and monitoring of the patient in the health area was decided. The experiences derived from this case report are presented. In Cuban medical literature no similar cases were found.

Downloads

Download data is not yet available.

References

1. Morales Cadena M, Campos Ramírez R, de Guevara Méndez ML, Archibaldo Hope J. Fibrosis Pulmonar: reporte de un caso. AN ORL MEX. [Internet]. 2007 [Citado 17 Abr 2010]; 52(4): [Aprox. 2p.]. Disponible en: http://www.medigraphic.com/pdfs/anaotomex/aom-2007/aom074f.pdf

2. Lahoz Zamarro MT, Leguía Pérez M, Sánchez Santos PJ. Linfomas malignos no Hodgkinianos de senos paranasales. ORL Aragón. [Internet]. 2005 [citado 17 Abr 2010]; 8(1): [aprox. 4p.]. Disponible en: http://www.saorl.org/File.aspx?Fil_ID=129

3. Ximena Montero P, Lisbeth Platzer M, Marcela Castillo F. Actualizaciones de Fibrosis Pulmonar. Rev. Otorrinolaringol. Cir. Cabeza Cuello. [Internet]. 2005 [citado 17 Abr 2010]; 65: [aprox. 11p.]. Disponible en: http://www.sochiorl.cl/indices/pdfs/65-3/10.pdf

4. Morales Cadena M, Campos Ramírez R, Ladrón de Guevara Méndez M, Archibaldo Hope J. Fibrosis Pulmonar: reporte de un caso. An ORL Mex [Internet]. 2007 [citado 17 Abr 2010]; 52(4): [aprox. 5p.]. Disponible en: http://www.medigraphic.com/pdfs/anaotomex/aom-2007/aom074f.pdf

5. Casariego Z, Micinquevich S, Laufer N, Ricar J. Fibrosis Pulmonar idiopática: Actualización y presentación de un caso clínico. Avances en Odontoestomatología[Internet]. 2006 [citado 17 Abril 2010] 22(6): [Aprox. 8p.]. Disponible en: http://scielo.isciii.es/pdf/odonto/v22n6/original1.pdf

6 Penizzotto M, Pascansky D. Drogas asociadas a enfermedad pleura l. Rev Am Resp. [Internet]. 2008 [Citado 29 de abril 2012]; 8(4): [aprox.5 p.]. Disponible en: http://www.ramr.org.ar/archivos/numero/ano_8_4_dic_2008/mere4_3.pdf

7. Paz-Ibarra JL. Disfunción tiroidea inducida por amiodarona en la práctica clínica.An. Fac. Med. [Internet]. 2011 [Citado 28 de mayo 2012]; 72(1). Disponible en: http://www.scielo.org.pe/scielo.php?pid=S1025-55832011000100012&script=sci_arttext

8. Silva MN, Bacellar P, Martins H, Tinoco N, Costa F. Fibrose pulmonar secundária ? amiodarona-A propósito de un caso clínico. Revista Portuguesa de Pneumología. [Internet]. 2006 [Citado 28 de mayo 2012]; XII (6): [Aprox.5p.]. Disponible en: http://redalyc.uaemex.mx/redalyc/src/inicio/ArtPdfRed.jsp?iCve=169718459007

9. Peñafort F. Amiodarona: A 50 años de su descubrimiento. Rev Méd Universitaria [Internet]. 2009 [Citado 4 de marzo 2010]; 5(2): [Aprox. 15 p.]. Disponible en: http://revista.medicina.edu.ar/vol05_02/pdf/dossier.pdf

10. González Gordaliza MC, Vicente Bártulos A, Sánchez Corral JA, Bernal Morell E. Patrón alveolar nodular como forma de presentación de la toxicidad pulmonar por amiodarona. Radiología. [Internet] 2006 [Citado 4 de marzo 2010]; 48(02): [Aprox. 3p.]. Disponible en: http://www.elsevier.es/es/revistas/radiologia-119/patron-alveolar-nodular-como-forma-presentacion-toxicidad-13087223-comunicaciones-breves-2006

11. Bernal Morell E, Hernández Madrid A, Marín Marín I, Rodríguez Pena R, González Gordaliza M C, Concepción Moro. Nódulos pulmonares múltiples y amiodarona. KL-6 como nueva herramienta diagnóstica. Rev Esp Cardiol. [Internet]. 2005 [Citado 4 de marzo 2010]; 58(4). Disponible en: http://www.revespcardiol.org/pt/node/2038333

Downloads

Published

2012-09-03

How to Cite

1.
Sandrino Sánchez M, Mitjans Fernández L, Madraso Calzadilla Y, Azcuy Ruiz M, Trujillo Milo I. Interstitial pulmonary disease caused by amiodarone: a case report. Rev Ciencias Médicas [Internet]. 2012 Sep. 3 [cited 2025 Aug. 30];16(4):148-57. Available from: https://revcmpinar.sld.cu/index.php/publicaciones/article/view/964

Issue

Vol. 16 No. 4 (2012)

Section

CASE REPORTS

License

Authors who have publications with this journal agree to the following terms: Authors will retain their copyrights and grant the journal the right of first publication of their work, which will be publication of their work, which will be simultaneously subject to the Creative Commons Attribution License (CC-BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.

Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a volume). Likewise, and according to the recommendations of the Medical Sciences Editorial (ECIMED), authors must declare in each article their contribution according to the CRediT taxonomy (contributor roles). This taxonomy includes 14 roles, which can be used to represent the tasks typically performed by contributors in scientific academic production. It should be consulted in monograph) whenever initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which may produce interesting exchanges and increase citations of the published work. (See The effect of open access). https://casrai.org/credit/